Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp > Here's some conferences that'll interest you BIO

<< Previous

Bullboard Posts

Next >>

Post by MoneyMouthon Mar 23, 2021 11:13am

580 Views

Post# 32857948

Here's some conferences that'll interest you BIO

June 30, 2021 American Diabetes Association, Scientific Sessions

Bachul PJ. Persistent Graft Function after Islet Allotransplantation into Pre-Vascularized Sernova Cell PouchTM Device: Preliminary Results from the University of Chicago

June 5, 2021 American Transplant Congress

Bachul PJ. Islet Allotransplantation into the Pre-Vascularized Sernova Cell PouchTM Device - Preliminary Results of the Phase I/II Prospective, Open-Label, Single-Arm Study at University of Chicago.

<< Previous

Bullboard Posts

Next >>

Nord Precious Metals reveals silver zone at Castle East